Alcohol Research Center, University of Louisville, Louisville, Kentucky
Research Article
Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation
Author(s): Vatsalya Vatsalya*, Fengyuan Li, Jane Frimodig, Nihar Shah, Amar Sutrawe and Wenke Feng
Background: Hyperuricemia has been reported in liver injury; however its role in the early stage of Alcohol-associated Liver
Disease (ALD) has not been examined yet. This study investigated the role of Serum Uric Acid (SUA) in alcohol-related liver
disease, gut barrier dysfunction, and inflammation activity. This study also evaluated the efficacy of abstinence, treatment
with thiamine and medical management to alleviate hyperuricemia.
Methods: 48 heavy drinking Alcohol Use Disorder (AUD) patients (34 males [M]/14 females [F]) participated in this study.
Patients were grouped by serum Alanine Aminotransferase (ALT) levels as group 1 (ALT ≤ 40 U/L, 7M/8F) and group 2
(ALT>41U/L, 27M/6F). All patients received open label thiamine 200 mg daily dose. Demographics, drinking history (using
Lifetime Drinking History [LTDH], an.. View more»